← All indications
Meningeal Carcinomatosis
Primary or secondary neoplasm in the ARACHNOID or SUBARACHNOID SPACE. It appears as a diffuse fibrotic thickening of the MENINGES associated with variable degrees of inflammation.
Drugs by status
Approved for this indication (2)
Phase 3 trials (4)
Phase 2 trials (5)
Phase 1 trials (1)
Organizations
Organization Involved with Phase 4 Indications (3)
Organization Involved with Phase 3 Indications (3)
Organization Involved with Phase 2 Indications (31)
- Kadmon
- Bristol-Myers Squibb
- Enzon
- Roche
- Genentech
- National Cancer Center, Korea
- National Cancer Institute (NCI)
- Centre Leon Berard
- Chang Gung University
- Harvard University
- Dartmouth University
- Duke University
- University of Washington
- Institut Bergonié
- Intergroupe Francophone de Cancerologie Thoracique
- Jilin University
- Seoul National University
- Taichung Veterans General Hospital
- Nanchang University
- Taipei Veteran General hospital
- University of Amsterdam
- University of Toulouse
- Netherlands Cancer Institute
- University of Montpellier
- Curie Institute
- National Taiwan University
- University of Texas at Houston
- University of Paris
- Sungkyunkwan University
- University of Grenoble
- +1 more
Organization Involved with Phase 1 Indications (17)
- Schering-Plough
- AstraZeneca
- GlaxoSmithKline
- Mundipharma
- Reata Pharmaceuticals, Inc.
- University of Pittsburgh
- Baylor University
- Brown University
- Pediatric Brain Tumor Consortium
- University of Milan
- University of Bonn
- University of Virginia
- Mayo Clinic
- International Extranodal Lymphoma Study Group
- University Amedeo Avogadro
- Memorial Sloan-Kettering Cancer Center
- Kazia Therapeutics Limited
Organization Involved with Other Experimental Indications (2)